Patents by Inventor Raymond J. Monnat

Raymond J. Monnat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210285933
    Abstract: Described herein are functional cell assays and methods for selecting a personalized anti-cancer treatment regimen that can improve treatment of cancer in a subject, identify resistance of the subject's cancer to one or more anti-cancer agents and/or validate the current drug treatment strategy.
    Type: Application
    Filed: July 3, 2019
    Publication date: September 16, 2021
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Pamela BECKER, Su-In LEE, Carl BLAU, Vivian OEHLER, Timothy MARTINS, Raymond J. MONNAT, Jr.
  • Publication number: 20200370067
    Abstract: Compositions, targeting reagents, modified cells, nucleic acid molecules, systems, and methods for identifying and selecting genomic safe harbor sites for transgene insertion and other genome engineering applications. These materials and methods can be used to develop desired genome engineering applications, such as transgene insertion and expression or genome modification, that take into account the application-specific needs for safety, functional silence, and accessibility and other factors that vary with a desired application's goals and target population. Representative examples of desired genome engineering applications include, but are not limited to, transgene insertion, such as therapeutic transgene insertion, functional gene editing, gene or chromosomal location-specific structural modification, cell marking, gene activation, and/or gene repression.
    Type: Application
    Filed: May 21, 2020
    Publication date: November 26, 2020
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: Raymond J. MONNAT, JR., Blake T. HOVDE, Stefan PELLENZ, Michael PHELPS
  • Patent number: 9518977
    Abstract: Methods and microfluidic apparatus are disclosed for drug prediction. A microfluidic apparatus has (a) a plate, (b) a plurality of wells defined in the plate, (c) a plurality of closed microchannels defined in the plate, and (d) a sample platform defining a plurality of open microchannels, where the plurality of closed microchannels are each in communication with one of the plurality of wells and one of the plurality of open microchannels of the sample platform.
    Type: Grant
    Filed: October 19, 2013
    Date of Patent: December 13, 2016
    Assignee: University of Washington Through Its Center For Commercialization
    Inventors: Albert Folch, Raymond J. Monnat, Chi-ting Chang, Lisa Horowitz, Christopher G. Sip, Robert C. Rostomily
  • Publication number: 20140113838
    Abstract: Methods and microfluidic apparatus are disclosed for drug prediction. A microfluidic apparatus has (a) a plate, (b) a plurality of wells defined in the plate, (c) a plurality of closed microchannels defined in the plate, and (d) a sample platform defining a plurality of open microchannels, where the plurality of closed microchannels are each in communication with one of the plurality of wells and one of the plurality of open microchannels of the sample platform.
    Type: Application
    Filed: October 19, 2013
    Publication date: April 24, 2014
    Inventors: Albert Folch, Raymond J. Monnat, Chi-ting Chang, Lisa Horowitz, Christopher G. Sip, Robert C. Rostomily